Akèy › Enfeksyon aparèy respiratwa › North Carolina
Etid klinik pou Enfeksyon aparèy respiratwa nan North Carolina
4 etid pou Enfeksyon aparèy respiratwa ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Durham
- Research Site, Winston-Salem
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Duke Vaccine and Trials Unit, Durham
- Duke Vaccine and Trials Unit, Durham
- Duke University - Main Hospital and Clinics, Durham
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07013474A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- Duke Vaccine and Trials Unit, Durham
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 64 · Tout sèks · Mizajou Aug 7, 2026 · NCT07730450Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- Wake Forest Baptist Health, Winston-Salem
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 12, 2024 · NCT02735707Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.